http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5475114-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_620ecb9324409347c27e96b6071503ee |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate | 1992-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1995-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d89846df8128952f5e942b76ec537b5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37cdbd1c3757f53e2be2a3fd25e84f10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e22751816f23a19ff963b89a1af1cd3f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94abed5728c69fc3f53415f62be71e17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cb740b84876c3a414ce41062aa22a8e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc46b9e1547fe426dde0ad4a29b4509a |
| publicationDate | 1995-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-5475114-A |
| titleOfInvention | Pyrazolotriazole derivatives |
| abstract | PCT No. PCT/JP92/01090 Sec. 371 Date Mar. 1, 1994 Sec. 102(e) Date Mar. 1, 1994 PCT Filed Aug. 27, 1992 PCT Pub. No. WO93/05044 PCT Pub. Date Mar. 18, 1993.This invention relates to a pyrazolotriazole derivative represented by the general formula: <IMAGE> wherein each symbol means as follows; R1, R3 and R4: one of them represents hydrogen, tetrazolylated biphenylmethyl or lower alkyl, R2: hydrogen, tetrazolylated biphenylmethyl, cycloalkyl or lower alkyl, and R5 and R6: these may be the same or different from each other, and each represents hydrogen, halogen, tetrazolylated biphenylmethyl, formyl, carboxyl, esterified carboxyl, cycloalkyl, lower alkoxy, lower alkoxycarbonyl, or lower alkyl which may be substituted with hydroxyl, formyl or carboxyl, provided that at least one of R1 to R6 is tetrazolylated biphenylmethyl, and the broken lines mean that the pyrazolotriazole ring forms three double bonds, or a pharmaceutically acceptable salt thereof, and to a process for the production thereof, wherein the above compound (I) is useful for treating various diseases caused by the physiological function of angiotensin II. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004110962-A1 |
| priorityDate | 1991-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1572.